d-alpha tocopherol has been researched along with osteoprotegerin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azarina, A; Ima-Nirwana, S; Maizatul-Neza, J; Nazrun, AS; Norazlina, M; Norliza, M | 1 |
| Ambroszkiewicz, J; Chelchowska, M; Gajewska, J; Laskowska-Klita, T; Sands, D | 1 |
| Chen, Q; Deng, L; Ding, Y; Fu, Q; Peng, Y; Wu, Y; Yang, M | 1 |
3 other study(ies) available for d-alpha tocopherol and osteoprotegerin
| Article | Year |
|---|---|
Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Male; Nicotine; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley; Vitamin E | 2010 |
Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis.
Topics: Acid Phosphatase; Biomarkers; Bone Density; Bone Resorption; Calcium; Child; Child, Preschool; Collagen Type I; Cystic Fibrosis; Female; Humans; Isoenzymes; Male; Osteocalcin; Osteoprotegerin; Peptides; Phosphates; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Vitamin A; Vitamin E | 2013 |
Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration.
Topics: Animals; Chromans; Chromatography, High Pressure Liquid; Emulsions; Female; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Osteoclasts; Osteoprotegerin; Polyethylene Glycols; RANK Ligand; Vitamin E | 2014 |